WO2004103560A1 - Catalytic composition and process for asymmetric hydrogenation - Google Patents

Catalytic composition and process for asymmetric hydrogenation Download PDF

Info

Publication number
WO2004103560A1
WO2004103560A1 PCT/GB2004/001755 GB2004001755W WO2004103560A1 WO 2004103560 A1 WO2004103560 A1 WO 2004103560A1 GB 2004001755 W GB2004001755 W GB 2004001755W WO 2004103560 A1 WO2004103560 A1 WO 2004103560A1
Authority
WO
WIPO (PCT)
Prior art keywords
catalyst
hydrogenation
substrate
composition
catalytic
Prior art date
Application number
PCT/GB2004/001755
Other languages
French (fr)
Inventor
Lee David Proctor
Anthony John Warr
Elliot James Lathom
Original Assignee
Phoenix Chemicals Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phoenix Chemicals Limited filed Critical Phoenix Chemicals Limited
Priority to US10/557,749 priority Critical patent/US20070173660A1/en
Priority to CA002526497A priority patent/CA2526497A1/en
Priority to JP2006530469A priority patent/JP2007502710A/en
Priority to AU2004241183A priority patent/AU2004241183A1/en
Priority to EP04729454A priority patent/EP1628762A1/en
Publication of WO2004103560A1 publication Critical patent/WO2004103560A1/en

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
    • B01J31/24—Phosphines, i.e. phosphorus bonded to only carbon atoms, or to both carbon and hydrogen atoms, including e.g. sp2-hybridised phosphorus compounds such as phosphabenzene, phosphole or anionic phospholide ligands
    • B01J31/2404—Cyclic ligands, including e.g. non-condensed polycyclic ligands, the phosphine-P atom being a ring member or a substituent on the ring
    • B01J31/2442—Cyclic ligands, including e.g. non-condensed polycyclic ligands, the phosphine-P atom being a ring member or a substituent on the ring comprising condensed ring systems
    • B01J31/2447—Cyclic ligands, including e.g. non-condensed polycyclic ligands, the phosphine-P atom being a ring member or a substituent on the ring comprising condensed ring systems and phosphine-P atoms as substituents on a ring of the condensed system or on a further attached ring
    • B01J31/2452—Cyclic ligands, including e.g. non-condensed polycyclic ligands, the phosphine-P atom being a ring member or a substituent on the ring comprising condensed ring systems and phosphine-P atoms as substituents on a ring of the condensed system or on a further attached ring with more than one complexing phosphine-P atom
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J38/00—Regeneration or reactivation of catalysts, in general
    • B01J38/48—Liquid treating or treating in liquid phase, e.g. dissolved or suspended
    • B01J38/60—Liquid treating or treating in liquid phase, e.g. dissolved or suspended using acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B53/00—Asymmetric syntheses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/30—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/30—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
    • C07C67/31—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by introduction of functional groups containing oxygen only in singly bound form
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/67—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids
    • C07C69/675—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids of saturated hydroxy-carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/06—1,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0046—Ruthenium compounds
    • C07F15/0053—Ruthenium compounds without a metal-carbon linkage
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2231/00—Catalytic reactions performed with catalysts classified in B01J31/00
    • B01J2231/60—Reduction reactions, e.g. hydrogenation
    • B01J2231/64—Reductions in general of organic substrates, e.g. hydride reductions or hydrogenations
    • B01J2231/641—Hydrogenation of organic substrates, i.e. H2 or H-transfer hydrogenations, e.g. Fischer-Tropsch processes
    • B01J2231/643—Hydrogenation of organic substrates, i.e. H2 or H-transfer hydrogenations, e.g. Fischer-Tropsch processes of R2C=O or R2C=NR (R= C, H)
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
    • B01J2531/02—Compositional aspects of complexes used, e.g. polynuclearity
    • B01J2531/0261—Complexes comprising ligands with non-tetrahedral chirality
    • B01J2531/0266—Axially chiral or atropisomeric ligands, e.g. bulky biaryls such as donor-substituted binaphthalenes, e.g. "BINAP" or "BINOL"
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
    • B01J2531/80—Complexes comprising metals of Group VIII as the central metal
    • B01J2531/82—Metals of the platinum group
    • B01J2531/821—Ruthenium

Definitions

  • the present invention relates to a process for asymmetric hydrogenation catalysis, more particularly to such a process performed using an acid-activated hydrogenation catalyst, and to a catalytic composition for use in such a process.
  • statin drugs which are used to reduce cholesterol and/or triglyceride levels in the body.
  • statin drugs include Atorvastatin (LipitorTM), Fluvastatin (LescolTM) and Rosuvastatin (CrestorTM).
  • WO-A-98/04543 discloses a one pot process for the preparation and isolation of esters of (S)-3,4-O-isopropylidine-3,4-dihydroxybutanoic acid, cyclic othoesters of (S)-3,4- dihydroxybutanoic acid, and (S)-3-hydroxybutyrolactone from a carbohydrate substrate.
  • US Patent No. 5,292,939 discloses a process for the preparation of 3,4- dihydroxybutanoic acid from a glucose source.
  • Useful pharmaceutical intermediates can be formed by the enantioselective hydrogenation of ⁇ -ketoesters.
  • the hydrogenation is catalyzed by halogen-containing BLNAP-Ru(II) complexes (Tetrahedron Letters, Vol. 32, No. 33, pp 4163-4166, 1991).
  • the BINAP ligand (2, 2'-bis (diphenylphosphino)-l, l'-binaphthyl) has the formula (1):
  • US Patent No. 6162951 discloses processes for the preparation of BTNAP catalysts suitable for use in catalyzing asymmetric hydrogenation reactions.
  • the use of Ru(OCOCH 3 ) 2 [ ⁇ S ⁇ -BLNAP] in the enantioselective hydrogenation of ethyl 4- chloroacetoacetate is reported by Kitamura et al in Tetrahedron Letters, Vol. 29, No. 13, pp 1555-1556, 1988.
  • Kitamura et al report that the reaction (scheme A) proceeds within 5 minutes giving the (R)-alcohol in 97% in enantiomeric excess.
  • EP-A-0295109 teaches a process for preparing an optically active alcohol which comprises a symmetrically hydrogenating a ⁇ -keto acid derivative in the presence of a ruthenium-optically active phosphine complex as a catalyst.
  • the resulting alcohol is said to have a high optical purity.
  • Other examples of asymmetric hydrogenation reactions, and catalysts therefor, are disclosed in United States Patent Nos. 5198561, 4739085, 4962242, 5198562, 4691037, 4954644 and 4994590.
  • a catalytic composition comprising a catalyst effective for catalysing asymmetric hydrogenation reactions, which catalyst requires acid activation, an acidic material effective for activating the catalyst, and a buffering compound or composition capable of forming, in the presence of the acidic material, an acetal, a ketal, a hemiacetal, and/or a hemiketal.
  • catalysts which are effective for enantioselective hydrogenation require acid activation.
  • Such catalysts include BINAP or other bisaryl bisphosphine- based ligand catalysts, for example [NH 2 Et 2 ] + [RuCl ⁇ p-MeO-B ⁇ NAP ⁇ 2 ⁇ -Cl ⁇ 3 ] " 5 [NH 2 Et 2 ] + RuCl(p- MeO-BrNAP) 2 ( ⁇ -Cl) 3 ], [RuI(p-cymene)(p-MeO-BLNAP)], [RuI(p-cymene)(p-Tol- BTNAP)]I, [RuI(p-cymene)(m-Tol-BL AP)]I, [RuI(p-cymene)(3,5-(t-Bu) 2 -BrNAP)]I, [RuI(p-cymene)(p-Cl-B ⁇ NAP)]I, [RuI(p-cy
  • Figure 1 shows a possible mechamsm for the asymmetric hydrogenation of ethyl-4- chloroacetoacetate in the presence of a BLNAP catalyst
  • Figure 2 shows in more detail the enantiomerically crucial hydrogenation step in Figure 1;
  • Figure 3 provides a possible mechanistic explanation of the buffering activity of an acetone/methanol mixture.
  • the ⁇ -keto group on the substrate is hydrogenated sequentially, the first hydrogenation step being effected by a hydrogen atom coordinated with the BINAP catalyst or, because an acid equilibrium is established, by a hydrogen ion from the acid solution.
  • the origin of the first hydrogenation has an important impact on enantioselectivity. If the first hydrogenation is effected by coordinated hydrogen, the enantiomeric excess is high because there remains only one coordinated hydrogen to effect the second hydrogenation. If the first hydrogenation is effected by hydrogen ions in the acid solution, the enantiomeric excess is low because there remain two coordinated hydrogens which can then attack from either side, giving different enantiomers as a result.
  • the enantiomeric excess of the desired product may be significantly improved by incorporating a buffering compound or composition in the reaction mixture. This may have the effect of driving the aforesaid equilibrium (shown in Figure 1) such that the first hydrogenation is effected by coordinated hydrogen, in preference to hydrogen ions from the acid solution.
  • Also provided in accordance with the invention is a process for the enantioselective catalytic hydrogenation of a hydrogenatable substrate comprising contacting the substrate with hydrogen and with a catalyst effective for enantioselective hydrogenation of the substrate, which catalyst requires acid activation, in the presence of an acidic material and a buffering compound or composition capable of forming, in the presence of the acidic material, an acetal, a ketal, a hemiacetal, and/or a hemiketal, under conditions effective for enantioselective hydrogenation of the substrate.
  • Buffering compounds and compositions for use in accordance with the invention suitably comprise mixtures of one or more aldehydes and/or ketones with one or more alcohols.
  • Examples include one or more of formaldehyde, acetaldehyde, propionaldehyde, n-butyraldehyde, benzaldehyde, p-tolualdehyde, salicyclaldehyde, phenylacetaldehyde, -methylvaleraldehyde, ⁇ -methylvaleraldehyde, isocaproaldehyde, acetone, methyl ethyl ketone, methyl n-propyl ketone, ethyl ketone, methyl isopropyl ketone, benzyl methyl ketone, acetophenone, n-butyrophenone and propylalcohol, isopropylalcohol, n-butylalcohol, isobut
  • FIG 3 there is shown a possible mechanistic explanation for the buffering activity of an acetone/methanol mixture. It is thought (although the scope of the invention is not to be considered as limited by such explanation) that the buffering action of the mixture allows sufficient hydrogen ions in solution to activate the hydrogenation catalyst but, in "mopping up” excess hydrogen ions, drives the equilibrium shown in Figure 1 in favour of the enantioselective hydrogenation route (ie away from the intermediate depicted at the bottom of Figure 1).
  • the process of the invention may suitably be operated as a batch or continuous process.
  • the reaction temperature is preferably maintained at least about 75°C, more preferably at least about 90°C and even more preferably at least about 100°C. In one preferred process according to the invention, the reaction temperature is from about 100 to about 150°C.
  • the buffering compound or composition suitable for use in the invention may act as a solvent for the hydrogenatable substrate.
  • reaction product mixture comprising enantioselectively hydrogenated ⁇ -ketoester, unreacted ⁇ - ketoester, catalyst and hydrogen;
  • the ⁇ -ketoester is preferably ethyl-4-chloroacetoacetate but is suitably of the formula (2):
  • X, R and R' are independently selected from hydrogen, optionally substituted alkyl, aryl, aryl alkyl or alkaryl groups or optionally substituted cyclo alkyl groups; and wherein X may alternatively be selected from fluorine, chlorine, bromine, iodine, mesylates, tosylates, sulphonate esters, tetra alkyl ammonium and other suitable leaving groups; and n is from 1 to 4.
  • the ⁇ -ketoester may have from 1 to 4 keto groups and may, for example, be a ⁇ , ⁇ - diketoester.
  • the hydrogenation zone is maintained at a pressure of at least about 75 bar, more preferably at least about 90 bar and still more preferably at least about 100 bar. In one preferred process according to the invention, the hydrogenation zone is maintained under conditions of from about 100 to about 150 bar.
  • the enantiomeric excess in the product is preferably greater than about 95%), more preferably greater than about 96%, yet more preferably greater than about 97% and most preferably greater than about 98%, for example about 99% or more.
  • Also provided in accordance with the present invention is a use of a buffering compound or composition in a process for the asymmetric catalytic hydrogenation of a substrate in the presence of an effective catalyst requiring acid activation, and of an acidic material for effecting such activation, which buffering compound or composition has the capacity to form an acetal, a ketal, a hemiacetal, and/or a hemiketal in the presence of the acidic material, to improve the enantiomeric excess of desired asymmetrically hydrogenated product.
  • a 600ml stainless steel Parr reactor was charged with ethanol (340ml) and ethyl-4- chloroacetoacetate (53g).
  • the reactor agitator was started and the speed set to 600rpm.
  • the reactor was pressurised using nitrogen to 7 bar and stirring continued for 5 minutes. After 5 minutes the reactor was slowly vented to ambient pressure, the pressurisation/depressurisation cycle was repeated for a total of five times to ensure complete removal of dissolved oxygen.
  • the reactor set- point temperature was adjusted to 95°C. (R)-[RuCl 2 (BLNAP)]n catalyst was accurately weighed (23mg) into a catalyst transfer vessel and the vessel then purged using nitrogen for 5 minutes.
  • the catalyst was flushed from the transfer vessel using deoxygenated solvent into a 100ml stainless steel injection bomb which was attached to the Parr reactor.
  • the injection bomb was pressurised to lOObar using hydrogen.
  • Appropriate valves were then opened to transfer the catalyst mixture and hydrogen into the reactor.
  • the contents of the reactor were stirred at 600rpm for 30 minutes before being cooled to less than 30°C.
  • the reactor was then slowly vented to ambient pressure.
  • the reactor contents were transferred into a 1L rotary film evaporator flask and the mixture evaporated to constant weight by application of vacuum and by using a heated water bath.
  • a 600ml stainless steel Parr reactor was charged with ethanol (170ml), acetone (170ml) and ethyl-4-chloroaceto acetate (53g).
  • the reactor agitator was started and the speed set to 600rpm.
  • the reactor was pressurised using nitrogen to 7 bar and stirring continued for 5 minutes. After 5 minutes the reactor was slowly vented to ambient pressure, the pressurisation/depressurisation cycle was repeated for a total of five times to ensure complete removal of dissolved oxygen.
  • the reactor set-point temperature was adjusted to 95°C. (R)-[RuCl 2 (BLNAP)]n catalyst was accurately weighed (23mg) into a catalyst transfer vessel and the vessel then purged using nitrogen for 5 minutes.
  • the catalyst was flushed from the transfer vessel using deoxygenated solvent into a 100ml stainless steel injection bomb which was attached to the Parr reactor.
  • the injection bomb was pressurised to lOObar using hydrogen.
  • Appropriate valves were then opened to transfer the catalyst mixture and hydrogen into the reactor.
  • the contents of the reactor were stirred at 600rpm for 30 minutes before being cooled to less than 30°C.
  • the reactor was then slowly vented to ambient pressure.
  • the reactor contents were transferred into a 1L rotary film evaporator flask and the mixture evaporated to constant weight by application of vacuum and by using a heated water bath.
  • a 600ml stainless steel Parr reactor was charged with ethanol (340ml) and 6-chloro-3,5- dioxo-hexanoic acid tert-butyl ester (76g).
  • the reactor agitator was started and the speed set to 600rpm.
  • the reactor was pressurised using nitrogen to 7 bar and stirring continued for 5 minutes. After 5 minutes the reactor was slowly vented to ambient pressure, the pressurisation/depressurisation cycle was repeated for a total of five times to ensure complete removal of dissolved oxygen.
  • the reactor set-point temperature was adjusted to 95°C. (R)-[RuCl 2 (BINAP)]n catalyst was accurately weighed (23mg) into a catalyst transfer vessel and the vessel then purged using nitrogen for 5 minutes.
  • the catalyst was flushed from the transfer vessel using deoxygenated solvent into a 100ml stainless steel injection bomb which was attached to the Parr reactor.
  • the injection bomb was pressurised to lOObar using hydrogen.
  • Appropriate valves were then opened to transfer the catalyst mixture and hydrogen into the reactor.
  • the contents of the reactor were stirred at ⁇ OOrpm for 30 minutes before being cooled to less than 30°C.
  • the reactor was then slowly vented to ambient pressure.
  • the reactor contents were transferred into a 1L rotary film evaporator flask and the mixture evaporated to constant weight by application of vacuum and by using a heated water bath.
  • a 600ml stainless steel Parr reactor was charged with ethanol (170ml), acetone (170ml) and 6-chloro-3,5-dioxo-hexanoic acid tert-butyl ester (76g).
  • the reactor agitator was started and the speed set to 600rpm.
  • the reactor was pressurised using nitrogen to 7 bar and stirring continued for 5 minutes. After 5 minutes the reactor was slowly vented to ambient pressure, the pressurisation/depressurisation cycle was repeated for a total of five times to ensure complete removal of dissolved oxygen.
  • the reactor set-point temperature was adjusted to 95°C.
  • a feed tank was charged with 1.8L acetone and 1.8L methanol solvent.
  • the solvent was deoxygenated by pumping it through a spray nozzle whilst pressurising to 7bar with nitrogen and then depressurising through a needle valve at a. controlled rate.
  • the pressurisation/depressurisation cycle was repeated three times and the entire process automated using a PLC-based control system.
  • a second feed tank was charged with ethyl-4-chloroacetoacetate (3.6L) and deoxygenated using the same protocol to that described above.
  • the catalyst, (R)-[RuCl 2 (BINAP)] n (149mg) was charged into a transfer vessel and the vessel purged using nitrogen before transferring the catalyst into the solvent feed tank.
  • the catalyst solution had a concentration of 52.2mg/Kg.
  • the two feed systems were connected to the continuous hydrogenation reactor system via two high-pressure pumps.
  • the continuous hydrogenation reactor system was constructed of Hastalloy 276 and comprised a number of in-line static mixers to give a residence time of between 30 and 35 seconds.
  • the static mixers also ensured good mixing of the process streams and rapid absorption of hydrogen.
  • the reactor system was equipped with a recycle pump and an in-line valve which enabled operation as either a plug flow reactor (PFR, valve closed) or a continuous loop reactor (CLR, valve open).
  • PFR plug flow reactor
  • CLR continuous loop reactor
  • the system was equipped with a gas/liquid separator and the liquid level inside the separator controlled using a differential pressure sensor, which in turn operated an exit flow control valve.
  • the reactor system was controlled using a PLC based control system.
  • the hydrogenation reactor was pressurised using hydrogen and the pressure maintained between 90 and 100 bar by continually feeding hydrogen through a mass flow controller at a rate of 2.7g/h.
  • the reaction liquors passed through a heat exchanger using a pump such that the process temperature was maintained between 102°C and 105°C.
  • the system above was operated as a plug flow reactor.
  • the flow rate of the efhyl-4- chloroacetoacetate was set to 2.6ml/minute and the flow rate of the catalyst solution set to 8.9ml/min. These flows gave a process concentration of 30%w/w and a substrate to catalyst ratio of 20,000:1.
  • the reactor was set up as in Example 5, except it was operated as a continuous loop reactor.
  • the flow rate of the ethyl-4-chloroacetoacetate was set to 2.55ml/minute and the flow rate of the acetone/methanol catalyst solution set to 6.60ml/min at a catalyst concentration of 45.8mg/kg. These flows gave a process concentration of 37%w/w and a substrate to catalyst ratio of 65,000:1.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Catalysts (AREA)

Abstract

The present invention concerns a catalytic composition comprising a catalyst effective for catalysing asymmetric hydrogenation reactions, which catalyst requires acid activation, an acidic material effective for activating the catalyst, and a buffering compound or composition capable of forming, in the presence of the acidic material, an acetal, a ketal, a hemiacetal, and/or a hemiketal. The invention also relates to an asymmetric hydrogenation process utilising such a catalytic composition, and to the use of such a catalytic composition for improving the enantiomeric excess of a desired asymmetrically hydrogenated product.

Description

CATALYTIC COMPOSITION AND PROCESS FOR ASYMMETRIC HYDROGENATION
The present invention relates to a process for asymmetric hydrogenation catalysis, more particularly to such a process performed using an acid-activated hydrogenation catalyst, and to a catalytic composition for use in such a process.
Asymmetric hydrogenation reactions are used in a wide variety of chemical processes, in particular in the manufacture of pharmaceutical intermediates. One particularly significant commercial area at present is in the manufacture of so-called statin drugs, which are used to reduce cholesterol and/or triglyceride levels in the body. Examples of current statin drugs include Atorvastatin (Lipitor™), Fluvastatin (Lescol™) and Rosuvastatin (Crestor™).
WO-A-98/04543 discloses a one pot process for the preparation and isolation of esters of (S)-3,4-O-isopropylidine-3,4-dihydroxybutanoic acid, cyclic othoesters of (S)-3,4- dihydroxybutanoic acid, and (S)-3-hydroxybutyrolactone from a carbohydrate substrate.
US Patent No. 5,292,939 discloses a process for the preparation of 3,4- dihydroxybutanoic acid from a glucose source.
Useful pharmaceutical intermediates can be formed by the enantioselective hydrogenation of β-ketoesters. The hydrogenation is catalyzed by halogen-containing BLNAP-Ru(II) complexes (Tetrahedron Letters, Vol. 32, No. 33, pp 4163-4166, 1991). The BINAP ligand (2, 2'-bis (diphenylphosphino)-l, l'-binaphthyl) has the formula (1):
Figure imgf000002_0001
US Patent No. 6162951 discloses processes for the preparation of BTNAP catalysts suitable for use in catalyzing asymmetric hydrogenation reactions. The use of Ru(OCOCH3)2[ {S}-BLNAP] in the enantioselective hydrogenation of ethyl 4- chloroacetoacetate is reported by Kitamura et al in Tetrahedron Letters, Vol. 29, No. 13, pp 1555-1556, 1988. Kitamura et al report that the reaction (scheme A) proceeds within 5 minutes giving the (R)-alcohol in 97% in enantiomeric excess. The same reaction was investigated by Pavlov et al in Russian Chemical Bulletin, Vol. 49, No. 4, April, 2000, pp 728-731. Pavlov et al studied the effects of the nature of the solvent, the reaction temperature, the pressure, addition of acids, and the reagent ratio on the yield and degree of an enantiomeric enrichment of the reaction products.
A substantial report in connection with reductions of 1, 3-dicarbonyl systems with ruthenium-biarylbisphosphine catalysts has been prepared by Ager and Laneman, reported in Tetrahedron, Asymmetry, Vol. 8, No.20, pp 3327-3355, 1997.
EP-A-0295109 teaches a process for preparing an optically active alcohol which comprises a symmetrically hydrogenating a β-keto acid derivative in the presence of a ruthenium-optically active phosphine complex as a catalyst. The resulting alcohol is said to have a high optical purity. Other examples of asymmetric hydrogenation reactions, and catalysts therefor, are disclosed in United States Patent Nos. 5198561, 4739085, 4962242, 5198562, 4691037, 4954644 and 4994590.
Our co-pending UK application No. 0211716.6 discloses a continuous process for the enantioselective catalytic hydrogenation of β-ketoesters. Our co-pending UK application No. 0211715.8 discloses a continuous process for cyanation of the resulting hydrogenated material.
One of the problems associated with asymmetric hydrogenation reactions in general, and with asymmetric hydrogenation of β-ketoesters in particular, is to maximise the enantiomeric excess of the desired asymmetrically hydrogenated product over its unwanted enantiomer. It is an object of the present invention to provide such an improvement. According to the present invention there is provided a catalytic composition comprising a catalyst effective for catalysing asymmetric hydrogenation reactions, which catalyst requires acid activation, an acidic material effective for activating the catalyst, and a buffering compound or composition capable of forming, in the presence of the acidic material, an acetal, a ketal, a hemiacetal, and/or a hemiketal.
Many catalysts which are effective for enantioselective hydrogenation require acid activation. Such catalysts include BINAP or other bisaryl bisphosphine- based ligand catalysts, for example [NH2Et2]+[RuCl{p-MeO-BιNAP}2{μ-Cl}3]" 5 [NH2Et2]+RuCl(p- MeO-BrNAP)2(μ-Cl)3], [RuI(p-cymene)(p-MeO-BLNAP)], [RuI(p-cymene)(p-Tol- BTNAP)]I, [RuI(p-cymene)(m-Tol-BL AP)]I, [RuI(p-cymene)(3,5-(t-Bu)2-BrNAP)]I, [RuI(p-cymene)(p-Cl-BιNAP)]I, [RuI(p-cymene)(p-F-BLNAP)]I, [Rul(p- cymene)(3,5-(Me)2-BLNAP)]I, [RuI(p-cymene)(H8-BINAP)]I, [Rul(p- cymene)(BIMOP)]I, [RuI(p-cymene)(FUMOP)]I, [RuI(p-cymene)(BIFUP)]I, [Rul(p- cymene)(BIPHEM)3I, [RuI(p-cymene)(MeOl-BLPHEP)]I, [RuCl2(tetraMe-
BITIANP)(DMF)n], [RuCl2(BITIANP)(DMF)n], [RuBr2(BLPHEMP)], [RuBr2(MeO- BLPHEMP)], [RuCl2(BINAP)]2(MeCN), [RuCl2(p-TolBLNAP)]2(MeCN), [RuCl2(MeO-BIPHEP)]2(MeCN)3 [RuCl2(BIPHEP)]2(MeCN), [RuCl2(BIPHEMP)]2, or [Ru( 3-2-Me-allyl)2(MeO-BIPFiEP)] or a combination of two or more thereof.
However, acidic conditions in asymmetric hydrogenation tend to lower the enantiomeric excess of the desired product. A possible mechanistic explanation for this is provided with reference to the following Figures, in which:
Figure 1 shows a possible mechamsm for the asymmetric hydrogenation of ethyl-4- chloroacetoacetate in the presence of a BLNAP catalyst;
Figure 2 shows in more detail the enantiomerically crucial hydrogenation step in Figure 1; and
Figure 3 provides a possible mechanistic explanation of the buffering activity of an acetone/methanol mixture. Referring to Figures 1, it will be seen that the β-keto group on the substrate is hydrogenated sequentially, the first hydrogenation step being effected by a hydrogen atom coordinated with the BINAP catalyst or, because an acid equilibrium is established, by a hydrogen ion from the acid solution. As is shown clearly in Figure 2, the origin of the first hydrogenation has an important impact on enantioselectivity. If the first hydrogenation is effected by coordinated hydrogen, the enantiomeric excess is high because there remains only one coordinated hydrogen to effect the second hydrogenation. If the first hydrogenation is effected by hydrogen ions in the acid solution, the enantiomeric excess is low because there remain two coordinated hydrogens which can then attack from either side, giving different enantiomers as a result.
The enantiomeric excess of the desired product may be significantly improved by incorporating a buffering compound or composition in the reaction mixture. This may have the effect of driving the aforesaid equilibrium (shown in Figure 1) such that the first hydrogenation is effected by coordinated hydrogen, in preference to hydrogen ions from the acid solution.
Also provided in accordance with the invention is a process for the enantioselective catalytic hydrogenation of a hydrogenatable substrate comprising contacting the substrate with hydrogen and with a catalyst effective for enantioselective hydrogenation of the substrate, which catalyst requires acid activation, in the presence of an acidic material and a buffering compound or composition capable of forming, in the presence of the acidic material, an acetal, a ketal, a hemiacetal, and/or a hemiketal, under conditions effective for enantioselective hydrogenation of the substrate.
Buffering compounds and compositions for use in accordance with the invention suitably comprise mixtures of one or more aldehydes and/or ketones with one or more alcohols. Examples include one or more of formaldehyde, acetaldehyde, propionaldehyde, n-butyraldehyde, benzaldehyde, p-tolualdehyde, salicyclaldehyde, phenylacetaldehyde, -methylvaleraldehyde, β -methylvaleraldehyde, isocaproaldehyde, acetone, methyl ethyl ketone, methyl n-propyl ketone, ethyl ketone, methyl isopropyl ketone, benzyl methyl ketone, acetophenone, n-butyrophenone and propylalcohol, isopropylalcohol, n-butylalcohol, isobutylalcohol, sec-butyl alcohol and tert-butylalcohol, but other compositions will be apparent to those skilled in the art. One particularly preferred buffering composition is acetone/methanol.
Referring to Figure 3, there is shown a possible mechanistic explanation for the buffering activity of an acetone/methanol mixture. It is thought (although the scope of the invention is not to be considered as limited by such explanation) that the buffering action of the mixture allows sufficient hydrogen ions in solution to activate the hydrogenation catalyst but, in "mopping up" excess hydrogen ions, drives the equilibrium shown in Figure 1 in favour of the enantioselective hydrogenation route (ie away from the intermediate depicted at the bottom of Figure 1).
The process of the invention may suitably be operated as a batch or continuous process. The reaction temperature is preferably maintained at least about 75°C, more preferably at least about 90°C and even more preferably at least about 100°C. In one preferred process according to the invention, the reaction temperature is from about 100 to about 150°C.
The buffering compound or composition suitable for use in the invention may act as a solvent for the hydrogenatable substrate.
In one preferred process according to the invention there is provided a continuous process for the enantioselective catalytic hydrogenation of β-ketoesters comprising:
(a) providing a catalytic hydrogenation zone maintained under conditions of temperature and pressure effective for the catalytic hydrogenation of β-ketoesters;
(b) continuously supplying to the catalytic hydrogenation zone a substrate comprising a β-ketoester to be hydrogenated, a catalyst, requiring acid activation, effective for enantioselective hydrogenation of the β-ketoester, an acidic material effective for activation of the catalyst, a buffering compound or composition capable of forming, in the presence of the acidic material, an acetal, a ketal, a hemiacetal, and/or a hemiketal and hydrogen; (c) contacting the substrate, the catalyst and the hydrogen in the hydrogenation zone for a residence time effective for at least partial enantioselective catalytic hydrogenation of the β-ketoester;
(d) continuously withdrawing from the hydrogenation zone a reaction product mixture comprising enantioselectively hydrogenated β-ketoester, unreacted β- ketoester, catalyst and hydrogen;
(e) supplying the reaction product mixture to a separation zone and separating at least some of the enantioselectively hydrogenated β-ketoester from the reaction product mixture;
(f) withdrawing the separated enantioselectively hydrogenated β- ketoester as product; and
(g) optionally supplying at least part of the remaining material from the separation zone to the hydrogenation zone.
The β-ketoester is preferably ethyl-4-chloroacetoacetate but is suitably of the formula (2):
Figure imgf000007_0001
wherein X, R and R' are independently selected from hydrogen, optionally substituted alkyl, aryl, aryl alkyl or alkaryl groups or optionally substituted cyclo alkyl groups; and wherein X may alternatively be selected from fluorine, chlorine, bromine, iodine, mesylates, tosylates, sulphonate esters, tetra alkyl ammonium and other suitable leaving groups; and n is from 1 to 4.
The β-ketoester may have from 1 to 4 keto groups and may, for example, be a β, δ - diketoester. Preferably, the hydrogenation zone is maintained at a pressure of at least about 75 bar, more preferably at least about 90 bar and still more preferably at least about 100 bar. In one preferred process according to the invention, the hydrogenation zone is maintained under conditions of from about 100 to about 150 bar.
A key requirement in the manufacture of a symmetrically hydrogenated substrates in general, and β-ketoesters in particular, is the so-called "enantiomeric excess" in the product of the desired enantiomer over the non-desired enantiomer. In the process of the invention, the enantiomeric excess in the product is preferably greater than about 95%), more preferably greater than about 96%, yet more preferably greater than about 97% and most preferably greater than about 98%, for example about 99% or more.
Also provided in accordance with the present invention is a use of a buffering compound or composition in a process for the asymmetric catalytic hydrogenation of a substrate in the presence of an effective catalyst requiring acid activation, and of an acidic material for effecting such activation, which buffering compound or composition has the capacity to form an acetal, a ketal, a hemiacetal, and/or a hemiketal in the presence of the acidic material, to improve the enantiomeric excess of desired asymmetrically hydrogenated product.
The invention will now be more particularly described with reference to the following Examples.
Example 1 ('comparative')
A 600ml stainless steel Parr reactor was charged with ethanol (340ml) and ethyl-4- chloroacetoacetate (53g). The reactor agitator was started and the speed set to 600rpm. The reactor was pressurised using nitrogen to 7 bar and stirring continued for 5 minutes. After 5 minutes the reactor was slowly vented to ambient pressure, the pressurisation/depressurisation cycle was repeated for a total of five times to ensure complete removal of dissolved oxygen. At the end of the last cycle the reactor set- point temperature was adjusted to 95°C. (R)-[RuCl2(BLNAP)]n catalyst was accurately weighed (23mg) into a catalyst transfer vessel and the vessel then purged using nitrogen for 5 minutes. The catalyst was flushed from the transfer vessel using deoxygenated solvent into a 100ml stainless steel injection bomb which was attached to the Parr reactor. When the Parr reactor temperature was between 95°C and 100°C the injection bomb was pressurised to lOObar using hydrogen. Appropriate valves were then opened to transfer the catalyst mixture and hydrogen into the reactor. The contents of the reactor were stirred at 600rpm for 30 minutes before being cooled to less than 30°C. The reactor was then slowly vented to ambient pressure. The reactor contents were transferred into a 1L rotary film evaporator flask and the mixture evaporated to constant weight by application of vacuum and by using a heated water bath. The residue was subjected to pot to pot distillation under vacuum to afford a clear colourless oily liquid product of ethyl (S)-(-)-4-chloro-3 -hydroxybutyrate in >98% yield, >98% purity and 94% enantiomeric excess.
Example 2
A 600ml stainless steel Parr reactor was charged with ethanol (170ml), acetone (170ml) and ethyl-4-chloroaceto acetate (53g). The reactor agitator was started and the speed set to 600rpm. The reactor was pressurised using nitrogen to 7 bar and stirring continued for 5 minutes. After 5 minutes the reactor was slowly vented to ambient pressure, the pressurisation/depressurisation cycle was repeated for a total of five times to ensure complete removal of dissolved oxygen. At the end of the last cycle the reactor set-point temperature was adjusted to 95°C. (R)-[RuCl2(BLNAP)]n catalyst was accurately weighed (23mg) into a catalyst transfer vessel and the vessel then purged using nitrogen for 5 minutes. The catalyst was flushed from the transfer vessel using deoxygenated solvent into a 100ml stainless steel injection bomb which was attached to the Parr reactor. When the Parr reactor temperature was between 95°C and 100°C the injection bomb was pressurised to lOObar using hydrogen. Appropriate valves were then opened to transfer the catalyst mixture and hydrogen into the reactor. The contents of the reactor were stirred at 600rpm for 30 minutes before being cooled to less than 30°C. The reactor was then slowly vented to ambient pressure. The reactor contents were transferred into a 1L rotary film evaporator flask and the mixture evaporated to constant weight by application of vacuum and by using a heated water bath. The residue was subjected to pot to pot distillation under vacuum to afford a clear colourless oily liquid product of ethyl (S)-(-)-4-chloro-3 -hydroxybutyrate in >98% yield, >99% purity and >98% enantiomeric excess. Example 3 (^Comparative)
A 600ml stainless steel Parr reactor was charged with ethanol (340ml) and 6-chloro-3,5- dioxo-hexanoic acid tert-butyl ester (76g). The reactor agitator was started and the speed set to 600rpm. The reactor was pressurised using nitrogen to 7 bar and stirring continued for 5 minutes. After 5 minutes the reactor was slowly vented to ambient pressure, the pressurisation/depressurisation cycle was repeated for a total of five times to ensure complete removal of dissolved oxygen. At the end of the last cycle the reactor set-point temperature was adjusted to 95°C. (R)-[RuCl2(BINAP)]n catalyst was accurately weighed (23mg) into a catalyst transfer vessel and the vessel then purged using nitrogen for 5 minutes. The catalyst was flushed from the transfer vessel using deoxygenated solvent into a 100ml stainless steel injection bomb which was attached to the Parr reactor. When the Parr reactor temperature » was between 95°C and 100°C the injection bomb was pressurised to lOObar using hydrogen. Appropriate valves were then opened to transfer the catalyst mixture and hydrogen into the reactor. The contents of the reactor were stirred at όOOrpm for 30 minutes before being cooled to less than 30°C. The reactor was then slowly vented to ambient pressure. The reactor contents were transferred into a 1L rotary film evaporator flask and the mixture evaporated to constant weight by application of vacuum and by using a heated water bath. The residue was subjected to pot to pot distillation under vacuum to afford a clear colourless oily liquid product of 3R,5S-(6-chloromethyl-2,2-dimethyl-[l,3]dioxin-4-yl)-acetic acid tert- butyl ester in >90% yield, >88% purity and 92% enantiomeric excess. Example 4
A 600ml stainless steel Parr reactor was charged with ethanol (170ml), acetone (170ml) and 6-chloro-3,5-dioxo-hexanoic acid tert-butyl ester (76g). The reactor agitator was started and the speed set to 600rpm. The reactor was pressurised using nitrogen to 7 bar and stirring continued for 5 minutes. After 5 minutes the reactor was slowly vented to ambient pressure, the pressurisation/depressurisation cycle was repeated for a total of five times to ensure complete removal of dissolved oxygen. At the end of the last cycle the reactor set-point temperature was adjusted to 95°C. (R)-[RuCl2(BINAP)]n catalyst was accurately weighed (23mg) into a catalyst transfer vessel and the vessel then purged using nitrogen for 5 minutes. The catalyst was flushed from the transfer vessel using deoxygenated solvent into a 100ml stainless steel injection bomb which was attached to the Parr reactor. When the Parr reactor temperature was between 95°C and 100°C the injection bomb was pressurised to lOObar using hydrogen. Appropriate valves were then opened to transfer the catalyst mixture and hydrogen into the reactor. The contents of the reactor were stirred at 600rpm for 30 minutes before being cooled to less than 30°C. The reactor was then slowly vented to ambient pressure. The reactor contents were transferred into a 1L rotary film evaporator flask and the mixture evaporated to constant weight by application of vacuum and by using a heated water bath. The residue was subjected to pot to pot distillation under vacuum to afford a clear colourless oily liquid product of 3R,5S-(6-chloromethyl-2,2-dimethyl-[l ,3]dioxin-4-yl)-acetic acid tert- butyl ester in >95% yield, >95% purity and >98% enantiomeric excess. Example 5
A feed tank was charged with 1.8L acetone and 1.8L methanol solvent. The solvent was deoxygenated by pumping it through a spray nozzle whilst pressurising to 7bar with nitrogen and then depressurising through a needle valve at a. controlled rate. The pressurisation/depressurisation cycle was repeated three times and the entire process automated using a PLC-based control system. In a similar manner a second feed tank was charged with ethyl-4-chloroacetoacetate (3.6L) and deoxygenated using the same protocol to that described above. The catalyst, (R)-[RuCl2(BINAP)]n (149mg) was charged into a transfer vessel and the vessel purged using nitrogen before transferring the catalyst into the solvent feed tank. The catalyst solution had a concentration of 52.2mg/Kg.
The two feed systems were connected to the continuous hydrogenation reactor system via two high-pressure pumps. The continuous hydrogenation reactor system was constructed of Hastalloy 276 and comprised a number of in-line static mixers to give a residence time of between 30 and 35 seconds. The static mixers also ensured good mixing of the process streams and rapid absorption of hydrogen. The reactor system was equipped with a recycle pump and an in-line valve which enabled operation as either a plug flow reactor (PFR, valve closed) or a continuous loop reactor (CLR, valve open). The system was equipped with a gas/liquid separator and the liquid level inside the separator controlled using a differential pressure sensor, which in turn operated an exit flow control valve. The reactor system was controlled using a PLC based control system. The hydrogenation reactor was pressurised using hydrogen and the pressure maintained between 90 and 100 bar by continually feeding hydrogen through a mass flow controller at a rate of 2.7g/h. The reaction liquors passed through a heat exchanger using a pump such that the process temperature was maintained between 102°C and 105°C.
The system above was operated as a plug flow reactor. The flow rate of the efhyl-4- chloroacetoacetate was set to 2.6ml/minute and the flow rate of the catalyst solution set to 8.9ml/min. These flows gave a process concentration of 30%w/w and a substrate to catalyst ratio of 20,000:1.
Over a series of continuous runs, each varying between 4 and 8 hours, the reactor consistently converted >99% ethyl-4-chloroacetoacetate to (S)-ethyl-4-chloro-3- hydroxybutyrate which was isolated after removing the solvents by evaporation to give a chemical yield of >98% and an enantiomeric excess greater than 99%. Example 6
The reactor was set up as in Example 5, except it was operated as a continuous loop reactor. The flow rate of the ethyl-4-chloroacetoacetate was set to 2.55ml/minute and the flow rate of the acetone/methanol catalyst solution set to 6.60ml/min at a catalyst concentration of 45.8mg/kg. These flows gave a process concentration of 37%w/w and a substrate to catalyst ratio of 65,000:1.
Over a series of continuous runs, each varying between 4 and 8 hours, the reactor consistently converted >99% ethyl-4-chloroacetoacetate to (S)-efhyl-4-chloro-3- hydroxybutyrate which was isolated after removing the solvents by evaporation to give a chemical yield of >98% and an enantiomeric excess greater than 99%.

Claims

1. A catalytic composition comprising a catalyst effective for catalysing asymmetric hydrogenation reactions, which catalyst requires acid activation, an acidic material effective for activating the catalyst, and a buffering compound or composition capable of forming, in the presence of the acidic material, an acetal, a ketal, a hemiacetal, and/or a hemiketal.
2. A catalytic composition according to claim 1, wherein the catalyst is a BINAP or other biaryl bisphosphine-based ligand catalyst.
3. A catalytic composition according to claim 1 or claim 2, wherein the catalyst is effective for catalysing the enantioselective hydrogenation of β-ketoesters.
4. A catalytic composition according to any one of claims 1 to 3, wherein the acidic material comprises a substrate suitable for asymmetric hydrogenation assisted by the catalyst.
5. A catalytic composition according to claim 4, wherein the substrate is ethyl- 4-chloroacetoacetate.
6. A catalytic composition according to any one of claims 1 to 5, wherein the buffering compound or composition comprises acetone and methanol.
7. A catalytic composition according to any one of claims 1 to 6, wherein the buffering compound or composition is suitable for use as a solvent or solvent system in an asymmetric hydrogenation reaction carried out in the presence of the catalytic compostion.
8. A process for the enantioselective catalytic hydrogenation of a hydrogenatable substrate comprising contacting the substrate with hydrogen and with a catalyst effective for enantioselective hydrogenation of the substrate, which catalyst requires acid activation, in the presence of an acidic material and a buffering compound or composition capable of forming, in the presence of the acidic material, an acetal, a ketal, a hemiacetal, and/or a hemiketal, under conditions effective for enantioselective hydrogenation of the substrate.
9. A process according to claim 8, wherein the catalyst is a BINAP or other biaryl bisphosphine-based ligand catalyst.
10. A process according to claim 9 or claim 10, wherein the catalyst is effective for catalysing the enantioselective hydrogenation of β-ketoesters.
11. A process according to any one of claims 8 to 10, wherein the acidic material comprises a substrate suitable for asymmetric hydrogenation assisted by the catalyst.
12. A process according to claim 11, wherein the substrate is ethyl-4- chloroacetoacetate.
13. A process according to any one of claims 8 to 12, wherein the buffering compound or composition comprises acetone and methanol.
14. A process according to any one of claims 8 to 13, wherein the buffering compound or composition is suitable for use as a solvent or solvent system in the asymmetric hydrogenation reaction.
15. Use of a buffering compound or composition in a process for the asymmetric catalytic hydrogenation of a substrate in the presence of an effective catalyst requiring acid activation, and of an acidic material for effecting such activation, which buffering compound or composition has the capacity to form an acetal, a ketal, a hemiacetal, and/or a hemiketal in the presence of the acidic material, to improve the enantiomeric excess of desired asymmetrically hydrogenated product.
PCT/GB2004/001755 2003-05-21 2004-04-26 Catalytic composition and process for asymmetric hydrogenation WO2004103560A1 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
US10/557,749 US20070173660A1 (en) 2003-05-21 2004-04-26 Catalytic composition and process for asymmetric hydrogenation
CA002526497A CA2526497A1 (en) 2003-05-21 2004-04-26 Catalytic composition and process for asymmetric hydrogenation
JP2006530469A JP2007502710A (en) 2003-05-21 2004-04-26 Catalyst composition and method for asymmetric hydrogenation
AU2004241183A AU2004241183A1 (en) 2003-05-21 2004-04-26 Catalytic composition and process for asymmetric hydrogenation
EP04729454A EP1628762A1 (en) 2003-05-21 2004-04-26 Catalytic composition and process for asymmetric hydrogenation

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0311658.9 2003-05-21
GB0311658A GB2401864B (en) 2003-05-21 2003-05-21 Process and catalytic composition

Publications (1)

Publication Number Publication Date
WO2004103560A1 true WO2004103560A1 (en) 2004-12-02

Family

ID=9958482

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2004/001755 WO2004103560A1 (en) 2003-05-21 2004-04-26 Catalytic composition and process for asymmetric hydrogenation

Country Status (7)

Country Link
US (1) US20070173660A1 (en)
EP (1) EP1628762A1 (en)
JP (1) JP2007502710A (en)
AU (1) AU2004241183A1 (en)
CA (1) CA2526497A1 (en)
GB (1) GB2401864B (en)
WO (1) WO2004103560A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5010312B2 (en) * 2007-03-02 2012-08-29 住友化学株式会社 Reaction initiation method for liquid phase reaction
EP2386536A1 (en) * 2010-05-11 2011-11-16 Lonza Ltd. A process for the hydrogenation of ketoesters

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003097581A1 (en) * 2002-05-22 2003-11-27 Phoenix Chemicals Limited Continuous process for the cyanation of hydrogenated beta-ketoesters
WO2003097569A1 (en) * 2002-05-22 2003-11-27 Phoenix Chemicals Limited Continuous process for the enantioselective catalytic hydrogenation of beta-ketoesters

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5198561A (en) * 1989-06-22 1993-03-30 Monsanto Company Ruthenium-BINAP asymmetric hydrogenation catalyst
CA2049536C (en) * 1991-05-13 1999-07-06 Rawle I. Hollingsworth Process for the preparation of 3,4-dihydroxybutanoic acid and salts thereof
US5412109A (en) * 1992-07-16 1995-05-02 Takasago International Corporation Process for preparing optically active 4-methyl-2-oxetanone
US5508435A (en) * 1992-07-29 1996-04-16 Merck & Co., Inc. Asymmetric hydrogenation of beta- or gamma-ketoesters and beta- or gamma-ketoamides
US6162951A (en) * 1996-09-20 2000-12-19 Oxford Asymmetry International Plc Phosphine ligands
FR2812638B1 (en) * 2000-08-03 2003-04-25 Ppg Sipsy USE OF CHIRAL DIPHOSPHINES AS OPTICALLY ACTIVE LIGANDS FOR THE PREPARATION OF DIPHOSPHINO-METALLIC COMPLEXES, THE COMPLEXES OBTAINED THEREBY AND THE ASYMMETRIC CATALYSIS PROCESSES USING THE SAME

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003097581A1 (en) * 2002-05-22 2003-11-27 Phoenix Chemicals Limited Continuous process for the cyanation of hydrogenated beta-ketoesters
WO2003097569A1 (en) * 2002-05-22 2003-11-27 Phoenix Chemicals Limited Continuous process for the enantioselective catalytic hydrogenation of beta-ketoesters

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
GENET J P ET AL: "Enantioselective hydrogenation reactions with a full set of preformed and prepared in situ chiral diphosphine-ruthenium(II) catalysts", TETRAHEDRON: ASYMMETRY, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, vol. 5, no. 4, 1994, pages 675 - 690, XP002249781, ISSN: 0957-4166 *
KING S A ET AL: "AN IMPROVED PROCEDURE FOR THE SYNTHESIS AND USE OF ÄRUCL2(BINAP)Ü2.NET3. DEPENDENCE OF THE RU(II)-BINAP CATALYZED ASYMMETRIC HYDROGENATION OF BETA-KETO ESTERS ON TRACE AMOUNTS OF ACID", JOURNAL OF ORGANIC CHEMISTRY, AMERICAN CHEMICAL SOCIETY. EASTON, US, vol. 57, 1992, pages 6689 - 6691, XP001121706, ISSN: 0022-3263 *
KITAMURA M ET AL: "A PRACTICAL ASYMMETRIC SYNTHESIS OF CARNITINE", TETRAHEDRON LETTERS, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, vol. 29, no. 13, 1988, pages 1555 - 1556, XP001033752, ISSN: 0040-4039 *
RATOVELOMANANA-VIDAL, V. ET AL: "Enantioselectivity hydrogenation of beta-keto esters using chiral diphosphine-Ruthenium complexes: optimisation for academic and industrial purposes and synthetic application", ADV. SYNTH. CATAL., vol. 345, 21 January 2003 (2003-01-21), pages 261 - 274, XP002290486 *
ZHOU Y-G ET AL: "HIGHLY EFFECTIVE CHIRAL ORTHO-SUBSTITUTED BINAPO LIGANDS (OMICRON-BINAPO): APPLICATIONS IN RU-CATALYZED ASYMMETRIC HYDROGENATIONS OF BETA-ARYL-SUBSTITUTED-BETA-(ACYLAMINO)ACRYLATES AND BETA-KETO ESTERS", JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, AMERICAN CHEMICAL SOCIETY, WASHINGTON, DC, US, vol. 124, 8 March 2002 (2002-03-08), pages 4952 - 4953, XP001106877, ISSN: 0002-7863 *

Also Published As

Publication number Publication date
US20070173660A1 (en) 2007-07-26
EP1628762A1 (en) 2006-03-01
AU2004241183A1 (en) 2004-12-02
GB2401864B (en) 2007-11-14
GB0311658D0 (en) 2003-06-25
GB2401864A (en) 2004-11-24
JP2007502710A (en) 2007-02-15
CA2526497A1 (en) 2004-12-02

Similar Documents

Publication Publication Date Title
US6399339B1 (en) Method for the enantioselective reduction of 3,5-dioxocarboxylic acids, their salts and their esters
JP7483818B2 (en) Process for the preparation of unsaturated carboxylic acids by carbonylation of allylic alcohols and their acylation products - Patents.com
Shuklov et al. Chemo‐Catalyzed Pathways to Lactic Acid and Lactates
US20070197799A1 (en) Novel bisphosphane catalysts
EP1506155B1 (en) Continuous process for the enantioselective catalytic hydrogenation of beta-ketoesters
EP1628762A1 (en) Catalytic composition and process for asymmetric hydrogenation
US20020035271A1 (en) Process for preparing oprtically active trimethyllactic acid and its ester
Blaser Industrial asymmetric catalysis: Approaches and results
JP4607182B2 (en) Enantioselective ring opening of oxetan-2-ones
US6399834B1 (en) Methods for producing chiral aldehydes
Sugimura et al. Enantiomer-differentiating hydrogenation of methyl 3-cyclopropyl-2-methyl-3-oxopropanoate over tartaric acid-modified nickel: Performance of heterogeneous catalyst in dynamic kinetic resolution
CN106905124B (en) Method for preparing optically active aldehyde or ketone
Starodubtseva et al. Enantioselective hydrogenation of ethyl 4-chloro-3-oxobutyrate in solutions of organic salts with recycling of the catalyst Ru-BINAP
EP1747205A1 (en) Pharmaceutical compositions
Blandin et al. Asymmetric Hydrogenation of 2, 4‐Dioxo Esters: Selective Synthesis of 2‐Hydroxy‐4‐oxo Esters and Direct Access to Chiral 2‐Hydroxy‐4‐butyrolactones
CZ94397A3 (en) Process for preparing 1,3 alkanedioles and 3-hydroxyaldehydes
CN116444386A (en) Synthesis method of chiral propargyl amino acid ester compound
US20040224990A1 (en) Enantioselective hydrogenation of intermediates in the synthesis of tipranavir
Coman et al. Asymmetric Catalysis by Heterogeneous Catalysts
Shimizu Palladium-Catalyzed Nucleophilic Allylation of Carbonyl Compounds with Allyl Alcohols

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DPEN Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed from 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2004729454

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2004241183

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 1238/MUMNP/2005

Country of ref document: IN

ENP Entry into the national phase

Ref document number: 2004241183

Country of ref document: AU

Date of ref document: 20040426

Kind code of ref document: A

WWP Wipo information: published in national office

Ref document number: 2004241183

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2006530469

Country of ref document: JP

Ref document number: 2526497

Country of ref document: CA

WWP Wipo information: published in national office

Ref document number: 2004729454

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2007173660

Country of ref document: US

Ref document number: 10557749

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 10557749

Country of ref document: US